Showing 101 - 120 results of 29,910 for search '(( significant effect release ) OR ( significant ((clinical decrease) OR (linear decrease)) ))', query time: 2.81s Refine Results
  1. 101
  2. 102
  3. 103

    Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

    Published 2021
    “…<p>Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). …”
  4. 104

    Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…<p>Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). …”
  5. 105

    Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…<p>Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). …”
  6. 106

    Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…<p>Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). …”
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115

    Image1_The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis.TIF by Sheng Chao (14799646)

    Published 2023
    “…<p>Objective: Tacrolimus formulation affects the outcomes of a renal transplant, while the effect of its immediate- to extended-release conversion remains controversial. …”
  16. 116

    Image2_The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis.TIF by Sheng Chao (14799646)

    Published 2023
    “…<p>Objective: Tacrolimus formulation affects the outcomes of a renal transplant, while the effect of its immediate- to extended-release conversion remains controversial. …”
  17. 117
  18. 118
  19. 119

    Table_1_Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes... by Jie Chen (5892)

    Published 2024
    “…</p>Conclusion<p>Circulating DPP-4 activity significantly decreases after SIIT. The change in circulating DPP-4 activity during the 3-month post-treatment phase has the potential to predict long-term remission.…”
  20. 120